Answers are grounded in this paper and cite their sources.
Among the potential causes of chronic kidney disease (CKD), mitochondrial respiratory chain (MRC) dysfunction, oxidative stress and inflammation have been implicated as contributor factors to the pathogenesis of this disorder. It is thought that CoQ10 supplementation may offer some therapeutic potential in the treatment of patients with CKD, since CoQ10 has a key role in normal MRC function, as well as having antioxidant and anti-inflammatory action. This article will outline the current knowledge on the use of CoQ10 in the treatment of CKD
No takes yet. Share an insight, caveat, or question.
Hargreaves et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: